Skip to content

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03614936
Acronym
ELAN-ONCOVAL
Enrollment
800
Registered
2018-08-03
Start date
2013-06-11
Completion date
2019-06-30
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inoperable Squamous Cell Cancer of the Head and Neck

Brief summary

Use by Oncologists of Validated Geriatric Assessment Tools: G8 Screening Test and Certain Tests for Thorough Geriatric Evaluation

Interventions

OTHERGeriatric Screening Test G8

Geriatric screening test (Oncodage-G8). The oncologist realizes it and proposes the oncological treatment which seems to him then the most adapted (treatment which can be different from that proposed after the oncological evaluation only).

OTHERGeriatric fragility test GERICO

GERICO geriatric frailty test (if possible the same day as the G8 and in any case in the same week): Realized by the oncologist, it includes: * the socio-cultural evaluation scale, * the ADL autonomy questionnaire, * assessment of locomotor disorders, * nutritional assessment, * the MMSE Cognitive Function Evaluation Questionnaire, * the GDS-4 mood rating scale, * the comorbidity assessment test (Charlson Index)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum

Inclusion criteria

* Subject aged 70 or over * Carrier of squamous cell carcinoma of the head and neck, locally advanced undergoing treatment by radiotherapy or metastatic / recurrence not accessible to treatment curative locoregional under treatment with chemotherapy. * Patient likely to be eligible for ELAN-RT or ELAN-FIT or ELAN-UNFIT trials. * Patients affiliated to a social security scheme

Exclusion criteria

* Person deprived of liberty or under guardianship, * Presence of a neuro-psychological condition, family, social, or geographical, which may hinder the smooth running of the study. * Patient expressing opposition to participation in this study

Design outcomes

Primary

MeasureTime frameDescription
Completion rateUp to 1 yearRate of completion of each of the geriatric fragility test questionnaires and the G8 questionnaire and duration of the geriatric evaluation performed by the oncologist

Countries

France

Contacts

Primary ContactJoel GUIGAY, MD, PhD
joel.guigay@nice.unicancer.fr0492031501
Backup ContactCécile MERTENS, MD
C.Mertens@bordeaux.unicancer.fr0556337828

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026